Abstract -The purpose of this study was to determine the serological and molecular prevalence of Bartonella spp. infection in a sick dog population from Brazil. At the São Paulo State University Veterinary Teaching Hospital in Botucatu, 198 consecutive dogs with clinicopathological abnormalities consistent with tick-borne infections were sampled. Antibodies to Bartonella henselae and Bartonella vinsonii subsp. berkhoffii were detected in 2.0% (4/197) and 1.5% (3/197) of the dogs, respectively. Using 16S-23S rRNA intergenic transcribed spacer (ITS) primers, Bartonella DNA was amplified from only 1/198 blood samples. Bartonella seroreactive and/or PCR positive blood samples (n = 8) were inoculated into a liquid pre-enrichment growth medium (BAPGM) and subsequently sub-inoculated onto BAPGM/blood-agar plates. PCR targeting the ITS region, pap31 and rpoB genes amplified B. henselae from the blood and/or isolates of the PCR positive dog (ITS: DQ346666; pap31 gene: DQ351240; rpoB: EF196806). B. henselae and B. vinsonii subsp. berkhoffii (pap31: DQ906160; rpoB: EF196805) co-infection was found in one of the B. vinsonii subsp. berkhoffii seroreactive dogs. We conclude that dogs in this study population were infrequently exposed to or infected with a Bartonella species. The B. henselae and B. vinsonii subsp. berkhoffii strains identified in this study are genetically similar to strains isolated from septicemic cats, dogs, coyotes and human beings from other parts of the world. To our knowledge, these isolates provide the first Brazilian DNA sequences from these Bartonella species and the first evidence of Bartonella co-infection in dogs.
INTRODUCTION
Bartonella are fastidious hemotropic bacteria, which cause long-lasting bac-of which are new and emerging human pathogens [8, 12, 16, 24] .
In dogs, infection with five Bartonella species has been described: B. clarridgeiae and B. vinsonii subsp. berkhoffii (hereafter B. v. berkhoffii) DNA was detected in aortic valves of six dogs with vegetative endocarditis, based upon independent studies [9, 14, 32] ; B. elizabethae DNA was detected in a dog with weight loss and sudden death [37] ; B. henselae DNA was sequenced from a dog with peliosis hepatis and from a dog with granulomatous hepatitis [22] ; and B. washoensis was isolated from a dog with mitral valve endocarditis [15] . A potentially new species closely related to B. clarridgeiae (proposed name B. rochalimaea) has been isolated from three dogs and from 22 gray foxes in California [32] 1 . To date, no studies have reported serological or molecular evidence of Bartonella infection in dogs from Brazil or other South American countries. With the notable exception of B. bacilliformis, there are only a limited number of reports describing human infection with other Bartonella species in South America. In Brazil, B. quintana was detected by PCR in an infant [3] and two fatal cases of endocarditis were associated with high B. henselae antibody titers [41] . In contrast to humans, B. henselae seroreactivity was reported in 46% of 102 cats 2 suggesting that exposure to this organism in Brazil may be 1 Henn J.B., Koehler J.E., Gabriel M., Kasten R.W., Brown R.N., Papageorgiou S., Chomel B.B., Zoonotic Bartonella spp. in domestic dogs and gray foxes from California, in: Proc. more prevalent than was previously recognized.
The objective of this study was to determine the serological and molecular prevalence of Bartonella infection in a subset of the sick dog population examined at a Veterinary Teaching Hospital in southeastern Brazil. Successful culture and molecular characterization of B. henselae and B. v. berkhoffii from two clinically ill dogs is also reported, including the first evidence of simultaneous infection with these two organisms in the same host.
MATERIALS AND METHODS

Study population
One hundred and ninety-eight EDTAanticoagulated blood and serum samples from dogs with historical, clinical and/or laboratory findings consistent with tickborne diseases were prospectively selected at a Veterinary Teaching Hospital at the College of Veterinary Medicine and Animal Husbandry (FMVZ -Unesp) in Botucatu, southeast Brazil (latitude 22
• 53 09 S, longitude 48
• 26 42 W) between October 2002 and November 2003. Dogs included in this study had at least three of the following clinical or laboratory criteria: presence of tick infestation at the time of examination, bleeding disorders (epistaxis, melena, ecchymosis, bleeding gums), neurological signs, inflammatory ocular disease (uveitis, chorioretinitis, hyphema), fever (rectal temperature > 39.4
• C), anemia (PCV < 35%), leukopenia (WBC < 6 000 cells/µL), thrombocytopenia (platelets < 150 000 cells/µL) and hyperproteinemia (total protein > 7.8 g/dL). Dogs treated with tetracycline or imidocarb dipropionate during the previous 30 days were excluded from the study population. This study was approved by the Medical Ethical and Animal Care Committee of São Paulo State University. In addition, each owner authorized blood collection and enrollment of the dog into the study.
From the selected dogs, two had Bartonella species detected by culture (techniques described below). Dog #1 was a 6.3 kg 2-year-old male Poodle that was examined because of anorexia, bleeding gums, cutaneous petechiae, and ecchymoses. The dog was febrile (39.7
• C) and infested with ticks. Hematological abnormalities included severe anemia (PCV = 14%; normal 39%), leukopenia (2 692/µL; normal 6 000/µL), thrombocytopenia (2 500/µL; normal 190 000/µL), and hypoproteinemia (4.6 g/dL; normal 6.1 g/dL). Cardiovascular abnormalities included hypotension (systolic blood pressure = 75 mmHg; normal 90 mmHg), myocardial dysfunction (fractional shortening = 24%; normal 30%) and increased serum cTnI concentration (3.05 ng/mL; normal 0.11 ng/µL). (42 • C) at the time of examination. Hematological abnormalities included mild anemia (PCV = 34%), monocytosis (1936/µL, normal 1100/µL), thrombocytopenia (50 500/µL) and hyperproteinemia (11.6 g/dL, normal 7.8 g/dL). ECG abnormalities were not detected and blood pressure was normal; however, echocardiography identified an increased left ventricle wall (14.5 mm) thickness resulting in reduction of left ventricular chamber size (33 mm) during diastole. All other infectious disease diagnostic tests described above for Dog #1 were also negative for Dog #2.
Serology-based assays
The microimmunofluorescence test (IFA) for the detection of anti-B. v. berkhoffii (isolate 93-CO-1, ATCC #51672) and anti-B. henselae (strain Houston-1, ATCC #49882) antibodies in canine sera was performed as described [30] . The starting dilution was at 1:16 and the cut-off for seroreactivity was defined at 1:64. Endpoint titers were determined as the last dilution at which brightly stained bacteria could be detected on a fluorescence microscope. Exposure to Leishmania chagasi and Rickettsia rickettsii was evaluated by IFA as described [42, 45] . The cut-off dilution for seroreactivity was defined at 1:64 for R. rickettsii, and 1:80 for L. chagasi. An ELISA-based test kit (SNAP 4Dx, IDEXX Laboratories, Inc., Westbrook, ME, USA) was used according to the manufacturer's instructions to detect Borrelia burgdorferi antibodies, as well as antigens of Dirofilaria immitis from dog serum. A microagglutination test for Leptospira interrogans with a cut-off dilution at 1:100 was performed as described [51] . One dog was not tested because of insufficient serum.
DNA extraction
DNA was extracted from 300 µL of each dog's frozen EDTA-blood pellet using a commercially available GFX Genomic Blood DNA Purification Kit (Amersham Biosciences, Piscataway, NJ, USA).
The final eluted volume was 200 µL per sample. The absence of PCR inhibitors was demonstrated by the amplification of a fragment of the constitutive gene for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein, an enzyme related to the glycolysis pathway that is expressed in all mammal cells [5, 7] .
DNA amplification-based assays
Bartonella 16S-23S ribosomal RNA intergenic spacer (ITS) PCR amplification
Bartonella genus screening was performed as described previously [34] . Amplification was performed in a 25 µL final volume reaction containing 2mM MgCl 2 , 0.625 units of Taq DNA polymerase (Takara Ex Taq, Takara Bio Inc, Shiga, Japan), 12.5 pmol of each primer (325s 5'-CTT CAG ATG ATG ATC CCA AGC CTT YTG GCG -3 and 1100as 5 -GAA CCG ACG ACC CCC TGC TTG CAA AGC A-3 ), 200 µM (each) dATP, dTTP, dCTP, and dGTP (Fisher Scientific, Pittsburgh, PA, USA) and 1 to 5 µL of DNA template, according to DNA concentration determined for each sample (5 to 200 ng/reaction). B. v. berkhoffii identity was established using specific ITS primers (46s: 5 -CCT CAT TCT TTA AAA AAA GAG GGC TTT TTA AG-3 and 590as: GAA AGC GCT AAC CCC TAA ACC GAT T-3 ) and the same PCR conditions. PCR was performed in a Mastercycler EP (Eppendorf, Hamburg, Germany) under the following conditions: a single hotstart cycle at 95
• C for 2 min followed by 55 cycles of denaturing at 94
• C for 15 s, annealing at 66
• C for 15 s, and extension at 72
• C for 15 s. Amplification was completed by an additional cycle at 72
• C for 1 min, and products were analyzed by 2% agarose gel electrophoresis under UV exposure. DNA from a healthy, specific pathogen-free dog was used as a PCR negative control. Plasmid clones of partial sequences of 16-23S ITS region of B. henselae Houston-1 (L35101) and B. v. berkhoffii type I (AF167988) were used as positive controls. The detection limit observed in 100% of 10 replicate reactions was 2.5 DNA copies of B. henselae and 5 copies of B. v. berkhoffii per reaction.
Bartonella heme-binding protein gene (pap31) PCR amplification
ITS region PCR positive dogs were subsequently tested for the pap31 bacteriophage associated gene [33] . Oligonucleotides for Bartonella genus 1s 5 -ACT TCT GTT ATC GCT TTG ATT TCR RCT-3 and 688as 5 -CAC CAC CAG CAA AAT AAG GCA TMA Y-3 were used at the same concentration and amplification conditions as described above, where the annealing temperature was 58
• C. B. henselae identity was established using specific pap31 forward primer (pap31 Bhs: 5 -TAA GGT TGA AAT AAC TGA TCC GAA T-3 ) in conjunction with the 688as reverse primer. Plasmid clones of partial sequences of pap31 gene of B. henselae Houston-1 (BX897699) and B. v. berkhoffii type I (AY663045) was used as a positive control. The detection limit observed in 100% of 10 replicate reactions was 5 copies per reaction for both organisms.
Bartonella RNA polymerase beta subunit (rpoB) gene PCR amplification
ITS region PCR positive dogs were subsequently tested for the rpoB gene. The following oligonucleotides were manually designed for Bartonella genus amplification: rpoB 1615s 5 -ATY ACY CAT AAR CGY CGT CTT TCT GCT CTT GG-3 and rpoB 2267as 5 -GGA TCT AAA TCT TCY GTY GCA CGR ATA CG-3 . The PCR conditions were similar as described above, with annealing temperature at 62
• C. As positive controls, DNA extracted from isolates of B. henselae Houston-1 (BX897699) and B. v. berkhoffii type I (ATCC strain 93-CO-1) were used as genomic equivalent (GE) serially diluted in DNA obtained from a specific pathogen-free dog. The detection limit for both organisms was 2.5 GE per reaction.
Other tick-borne pathogen DNA amplification-based assays
Because of the risk of polymicrobial infection, other tick-borne pathogens were evaluated. Anaplasma and Ehrlichia 16S rRNA gene was targeted by conventional PCR [10, 30] with a detection limit of 10 copies per reaction in 100% of 10 replicates. Rickettsia spotted-fever species were screened by real-time PCR targeting the ompA gene [44] with a detection limit of 5 copies per reaction in 96% of 22 replicates.
Bartonella species culture
Two hundred microliters of blood from Bartonella ITS region-PCR positive dogs and/or IFA seroreactive dogs were inoculated into liquid Bartonella alpha-Proteobacteria growth medium (BAPGM) [35] and incubated at 35
• C in 5% CO 2 , water-saturated atmosphere. After a 14-day incubation period, 1 mL from liquid culture was sub-inoculated onto BAPGM/blood-agar plates and incubated for 14 days. For maximization of Bartonella DNA recovery, multiple bacterial colonies were collectively swabbed from the surface of each BAPGM/blood-agar plate, resuspended in sucrose-phosphateglutamate (SPG) buffer and stored at −80
• C until processed for DNA extraction. DNA from 200 mL of BAPGM liquid culture and from frozen SPG bacterial colonies was extracted using a commercially available MagAttract DNA blood kit (BioRobot M48, Qiagen, Chatsworth, CA, USA).
Cloning and sequencing of ITS region and pap31 gene amplicons
PCR products obtained from EDTAanti-coagulated blood, BAPGM liquid culture and/or the plate colonies were cloned into plasmid pGEM-T Easy Vector System (Promega, Madison, WI, USA) and the recombinants selected based on white/blue screening, EcoR I digestion and 2% agarose gel electrophoresis. After plasmid purification using commercial kit (QIAprep Spin Miniprep, Qiagen, Valencia, CA, USA), clones were sequenced by Davis Sequencing (Davis, CA, USA). Chromatogram evaluation and sequence alignment were performed using ContigExpress and AlignX softwares (Vector NTI Suite 10.1, Invitrogen Corp., Carlsbad, CA, USA). Bacteria species and strain were defined by comparing similarities with other sequences deposited in the GenBank database prior to April 2007 using the Basic Local Alignment Search Tool (Blast version 2.0) [1] .
Cardiac evaluation
Bartonella infected and/or seroreactive dogs were evaluated for cardiac disturbances. Non-invasive blood pressure was established using a Doppler ultrasonographic method (DV-10, Microem, Brazil) [46] . An electrocardiogram (ECG) was recorded with a 12-lead computerbased system (ECG-PC, TEB, Brazil) [49] . Echocardiography was performed with a 5 MHz electronic ultrasound probe (EUB-405, Hitachi, Norcross, GA, USA) [13] . 
Culture and molecular characterization of B. henselae and B. vinsonii subsp. berkhoffii
From the only PCR-positive blood sample (Dog #1), several colonies were obtained from the BAPGM/blood-agar culture, from which DNA was collectively extracted. The ITS region and pap31 gene amplicons from these colonies were of the expected size for B. henselae (Fig. 1) . DNA sequences from blood, BAPGM liquid culture, and the plate isolates were 100% homologous. Sequences were deposited into the GenBank database under accession numbers DQ346666 (ITS) and DQ351240 (pap31 gene).
Blood from each of the seven Bartonella seroreactive dogs was also cultured, and from a second patient (Dog #2) several colonies were obtained. After extracting DNA of these colonies conjointly, ITS region PCR amplicons were 100% homologous (604/604 bp) with B. henselae strain Houston-1 (BX897699 
Cardiac evaluation
In addition to the two cases reported in detail above, four other Bartonella spp. seroreactive dogs had evidence of cardiac disease. Dogs #3 and #4 (Tab. I) were seroreactive to B. henselae. Dog #3 had diastolic left ventricular enlargement and increased cTnI of 0.28 ng/mL (normal 0.11 ng/mL). Dog #4 had increased cTnI (0.51 ng/mL). Dogs #7 and #8 were B. v. berkhoffii seroreactive (Tab. I) and, despite cTnI levels within normal range, Dog #7 had evidence of myocardial dysfunction (fractional shortening = 22.3%; normal 30%) and Dog #8 had left ventricle enlargement. No dog had echocardiographic findings consistent with infective endocarditis or was hypertensive. In total, 6 of 8 IFA and/or PCR Bartonella spp. positive dogs had cardiac abnormalities.
DISCUSSION
To our knowledge, this study provides the first data relative to B. henselae and B. v. berkhoffii serological and molecular prevalence in dogs from Brazil. In addition, this is the first report of Bartonella species isolation from dogs from South America and the first documentation of co-infection with two Bartonella species in a dog. In 2004, B. henselae DNA was reported for the first time in a blood culture isolate obtained from a dog from Gabon [23] ; however, no information about amplicon size, strain and genetic sequence was provided. The Bartonella seroprevalences detected in this study were lower than expected for a country with tropical and sub-tropical climates. B. henselae seroreactivity was detected from 3.0% (3/100) of dogs in the United Kingdom [6] , 7.7% (4/52) of dogs in Japan [50] and 27.2% (82/301) of sick dogs in North Carolina [43] . Bartonella vinsonii subsp. berkhoffii antibodies were detected in 10% (4/40) of dogs from Israel [4] and in 38% (19/49) of dogs from Thailand [48] . Bartonellosis may predispose the host to insidious nonspecific manifestations; therefore, we can not exclude a selection bias, based upon narrowly defined entry criteria of this study.
Cats are the main reservoir of Bartonella spp. infection for humans [16] . However, based upon serological evidence, human cases of bartonellosis have also implicated dogs as a source of B. henselae infection [28, 52] . B. v. berkhoffii has been detected by PCR in dogs, coyotes and foxes [29, 36] ; however, the extent to which dogs contribute to the transmission of Bartonella to humans is unknown [24] . In Brazil, Rhipicephalus sanguineus, the most prevalent tick that infests dogs [18] also parasitizes humans [17, 21] . Epidemiological evidences suggest that R. sanguineus may be involved in the transmission of Bartonella species in dogs [39] . CAL-1
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* Sequence not deposited at GenBank database because it is 100% homologous to other sequences. Thus, this tick potentially could pose a risk for human infection. Dog #1 in this study, co-infected with B. henselae and E. canis, had a clinical diagnosis compatible with myocarditis, based upon cardiac dysfunction and high cTnI level, a cardiac biomarker highly specific and sensitive for myocardial injury [38] . Moreover, 6 of 8 (75%) Bartonella seroreactive or PCR positive dogs had evidence of cardiac disease. Myocardial injury has been reported in infective endocarditis in dogs [11, 32] and in human bartonellosis [25, 47] . Surprisingly, there was not echocardiographic evidence of endocarditis in any dog in this study. Seven of eight Bartonella seropositive or PCR positive dogs were infected with E. canis, a tick-transmitted, obligatory intracellular bacterium that is also associated with myocardial injury 3 . Hence, abnormalities detected in this study could have been due to infection with either E. canis or E. canis, B. v. berkhoffii and B. henselae co-infection, and/or due to other undetermined factors.
Three genes were targeted in this study to confirm Bartonella co-infection in Dog #2 and to better characterize the B. henselae isolate from Dog #1. Partial ITS region sequences obtained from Dog #1 were 100% homologous to B. henselae CAL-1 (546 bp/546 bp) (Tab. IV), which was isolated from a septicemic human being in the USA [27] . However, partial pap31 sequences were 99.8% homologous to strain Fizz (514 bp/514 bp) (Tab. III), which was isolated from a bacteremic cat in Switzerland [26] . These two strains (CAL-1 and Fizz) are 98% homologous within the ITS region (971/983 bp) and 100% homologous within pap31 gene. This suggests that B. henselae strains CAL-1 and Fizz may belong to the same genetic variant, as suggested previously [2] . The rpoB gene sequences from Dog #1 were 99.8% homologous (655/656 bp) to B. henselae Houston-1. Potentially, the discrepancy among sequenced genes from Dog #1 can be explained by the absence of CAL-1 and Fizz rpoB sequences in the GenBank database and by the high homology of rpoB gene among Bartonella species. Sequences of longer length and targeting additional genes would be necessary for a more complete phylogenetic classification of this B. henselae isolate [31] .
In this study, unanticipated co-infection with B. henselae and B. v. berkhoffii was successfully documented in a dog for the first time (Dog #2). By independently targeting the ITS region and pap31 gene with species-specific primers, Dog #2 was found to be co-infected with B. henselae Houston-1 and B. v. berkhoffii type I. The B. v. berkhoffii pap31 sequence from Dog #2 differed in 1 bp among 548 bp from a B. v. berkhoffii type I isolate (Y-12) obtained from a coyote [36] and 3 bp from B. v. berkhoffii type I (strain 93-CO-1, ATCC 51672) isolated from a dog with endocarditis [29] . Targeting a third gene (rpoB), infection with B. v. berkhoffii was confirmed (100% homology (656/656 bp) with strain 93-CO-1). Because colonies containing both organisms were unknowingly pooled and extracted together, molecular confirmation of co-infection by targeting multiple genes was required. This observation indicates that dogs, as is well recognized for cats, can be co-infected with more than one Bartonella species.
Bartonella PCR and IFA test results were discrepant among many of the dogs in this study (Tab. I). Different antigenic expression among Bartonella strains could result in false negative serology results, as previously shown in humans [19] and documented in our laboratory [20] . Gene expression and pathogenicity of B. henselae strains are based upon incompletely characterized mechanisms and do not directly correlate with genetic differences [40] . Furthermore, since clinically ill dogs were selected for this study, acute infection cases might have been preferentially included, resulting in PCR positivity prior to development of a detectable humoral immune response, as found in Dog #1.
In conclusion, the low prevalence of amplifiable Bartonella DNA in conjunction with low B. henselae and B. v. berkhoffii seroreactivity detected in this study indicates that these pathogens are uncommonly transmitted to dogs with a high risk of tick infestation in southeastern Brazil. The two species of Bartonella detected from sick dogs in Brazil were homologous to other species previously isolated from septicemic human beings, coyotes or dogs from the USA. Bartonella co-infection with E. canis or A. platys might increase disease severity and contribute to myocardial disease.
